SCHEMBL25017766

SCHEMBL25017766

c1ccc(-c2nc(-c3cccc4sc5ccccc5c34)nc(-c3cccc4sc5c(-c6nc(-c7ccccc7)c7sc8ccccc8c7n6)cccc5c34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 3/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ ATM Q13315 2/20 0.35
▸ ALOX5 P09917 1/20 0.33
▸ TNKS O95271 2/20 0.32
▸ TNKS2 Q9H2K2 2/20 0.32
▸ MAPT P10636 3/20 0.32
▸ GAA P10253 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32
▸ DPP4 P27487 1/20 0.32
▸ MAPK1 P28482 2/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ MMP14 P50281 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ CDK5 Q00535 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22195475 1.00 LIMK1 (0.36) LIMK1MEN1KMT2AATMALOX5
SCHEMBL22329477 0.98 LIMK1 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL22195818 0.98 LIMK1 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL25017010 0.97 MEN1 (0.39) LIMK1MEN1KMT2AATMALOX5
SCHEMBL22195675 0.95 ALOX5 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL25017055 0.95 ALOX5 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL22329998 0.95 MEN1 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL22195581 0.95 MEN1 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL22330286 0.95 MEN1 (0.38) LIMK1MEN1KMT2AATMALOX5
SCHEMBL25016428 0.94 ALOX5 (0.40) LIMK1MEN1KMT2AATMALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 LIMK1 389/4885MEN1 1118/4885KMT2A 3445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback